Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurore Dougé

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|June 7, 2017
[Pomalidomide for multiple myeloma]Aurore Dougé, Richard Lemal, Carine Chaleteix
Cancer Medicine|January 9, 2025
DNA Methylation in Prostate Cancer: Clinical Implications and Potential ApplicationsRomane Muletier, Céline Bourgne, Laurent Guy, et al.
Bulletin Du Cancer|January 19, 2024
[Cell therapy in all its forms]Aurore Dougé, Christophe Caux, Jacques-Olivier Bay
Bulletin Du Cancer|October 5, 2019
[Intestinal microbiota and allogeneic stem cell transplantation]Aurore Dougé, Jacques-Olivier Bay, Aurélie Ravinet, et al.
Molecular Cancer Therapeutics|October 30, 2023
Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming ImprovementsAurore Dougé, Nathan El Ghazzi, Richard Lemal, et al.
Bulletin Du Cancer|December 21, 2022
[CAR-T cells development in solid tumors]Nathan El Ghazzi, Antoine Italiano, Jacques-Olivier Bay, et al.
Bulletin Du Cancer|March 4, 2024
[The circulating PD-L1: An emerging predictive biomarker for immune checkpoint inhibitors response]Fanny Chovet, Anne-Sophie Passot, Quentin Mangon, et al.
Bulletin Du Cancer|December 18, 2021
[T cell-based immunotherapies in solid tumors]Estelle Baulu, Aurore Dougé, Nicolas Chuvin, et al.
Bulletin Du Cancer|January 30, 2016
[Ibrutinib prescription in B-cell lymphoid neoplasms]Aurore Dougé, Aurélie Ravinet, Jacques-Olivier Bay, et al.
Respiratory Medicine and Research|May 15, 2026
Defining intensive care status in metastatic lung cancer patients: A French surveyMarie Herbreteau, Céline Lambert, Patrick Merle, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|June 7, 2017
[Pomalidomide for multiple myeloma]Aurore Dougé, Richard Lemal, Carine Chaleteix
Cancer Medicine|January 9, 2025
DNA Methylation in Prostate Cancer: Clinical Implications and Potential ApplicationsRomane Muletier, Céline Bourgne, Laurent Guy, et al.
Bulletin Du Cancer|January 19, 2024
[Cell therapy in all its forms]Aurore Dougé, Christophe Caux, Jacques-Olivier Bay
Bulletin Du Cancer|October 5, 2019
[Intestinal microbiota and allogeneic stem cell transplantation]Aurore Dougé, Jacques-Olivier Bay, Aurélie Ravinet, et al.
Molecular Cancer Therapeutics|October 30, 2023
Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming ImprovementsAurore Dougé, Nathan El Ghazzi, Richard Lemal, et al.
Bulletin Du Cancer|December 21, 2022
[CAR-T cells development in solid tumors]Nathan El Ghazzi, Antoine Italiano, Jacques-Olivier Bay, et al.
Bulletin Du Cancer|March 4, 2024
[The circulating PD-L1: An emerging predictive biomarker for immune checkpoint inhibitors response]Fanny Chovet, Anne-Sophie Passot, Quentin Mangon, et al.
Bulletin Du Cancer|December 18, 2021
[T cell-based immunotherapies in solid tumors]Estelle Baulu, Aurore Dougé, Nicolas Chuvin, et al.
Bulletin Du Cancer|January 30, 2016
[Ibrutinib prescription in B-cell lymphoid neoplasms]Aurore Dougé, Aurélie Ravinet, Jacques-Olivier Bay, et al.
Respiratory Medicine and Research|May 15, 2026
Defining intensive care status in metastatic lung cancer patients: A French surveyMarie Herbreteau, Céline Lambert, Patrick Merle, et al.
Pageof 2